RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
MINERVA UROLOGY AND NEPHROLOGY
Collezione AO Ordine Mauriziano

Items : 3

Increase of continuous treatments and regional citrate anticoagulation during renal replacement therapy in the ICUs of the North-West of Italy from 2007 to 2015. in Minerva urology and nephrology / Minerva Urol Nephrol. 2023 Jun;75(3):388-397. doi: 10.23736/S2724-6051.22.04699-7. Epub 2022 Mar 11.

2023
ASL Città di Torino
ASL Vercelli
ASL Asti
ASL Torino 4
ASL VCO
ASL Cuneo 1
ASL Cuneo 2
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo
AOU Città della Salute di Torino
ASL Alessandria
AOU Alessandria
ASL Novara

Roccatello D; Biancone L; Cusinato S; Besso L; Manganaro M; Mariano F; Vitale C; Chiarinotti D; Boero R; Cesano G; Filiberti O; Costantini L; Borzumati M; Vio P; Chiappero F; Todini V; Marciello A; Savoldi S; Deagostini C; Serra A; Martina G; Salomone M; Formica M; Stramignoni E; Gherzi M; Calabrese G; Roscini E; Maffei S; Marino A; et alii...

Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):703-713. doi: 10.23736/S2724-6051.22.04701-2. Epub 2022 Feb 11.

2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Pisano C; DI Maio M; Tucci M; Scagliotti GV; Samuelly A; DI Stefano RF; Turco F; Bungaro M; Parente A; Buttigliero C; Angusti T;

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.

2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
ASL Torino 4
AO Ordine Mauriziano

Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Vignani F; Bungaro M; Samuelly A; Turco F; DI Stefano RF; Tucci M; Pisano C;